Data & Technology

Dr. Liz Kwo of Everly Health outlines 2023 predictions for AI, including how it can be beneficial to patients

Action enables the company to begin offering its unit-load device for shipments

Semiannual update includes better revenue forecasting and state reporting

Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton

How taking steps to incorporate data into all regulatory and labeling operations helps firms avoid retroactively planning to recapture information

Dr. Troy Sarich of Janssen reveals the company's approach to tackling financial challenges as they pertain to tech

Featuring manufacturing technology, the new facility supports medicines supply chain resilience

Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization

How to make commercial AI actionable in the last mile, helping to better realize data science investment and improve customer engagement

How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients

How privacy and technology literacy can coexist behind a blockchain-based approach to patient data analytics and control

How artificial intelligence is improving the patient experience

Biotech company’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs

Report shows US healthcare professional access approaching 80% in ‘key specialties’

How digital adoption is driving pharmacovigilance

Can help facilitate digital identification of medications

Agreement revolves around sustainability, but also features implementation of new bioprocess development methods

While this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue

Why biopharma and biotech companies must understand the availability, strengths, and limitations of RWD methods

Ten-year digital partnership aims to enhance patient experience

Center implements Industry 4.0 principles

WEF honor is for demonstration of leadership in adopting Industry 4.0 tech

Expected to improve patient centricity, simplify clinical development process through commercialization

Powered by tech company’s platform that strives to accelerate clinical development, commercialization of new therapies

While all drug development efforts are fraught with peril, a growing number of biopharma companies—large and small—are staking a claim in the rare disease treatment space, chasing odds that could yield clinical and financial rewards